House Bill 635 would require most health benefit plans in North Carolina’s large group market to cover fertility diagnostic care, fertility treatment, and fertility preservation services. The bill defines those terms broadly to include testing, medications, procedures, and services intended to diagnose fertility issues, achieve pregnancy, or preserve reproductive material for future use. It also specifies that covered fertility treatment must include at least three in vitro fertilization cycles per insured, including egg retrieval and fresh or frozen embryo transfer.
The bill limits the mandate in several ways. It does not apply to self-insured group health plans or health plans offered by religious institutions. Coverage would only be required for procedures performed at licensed healthcare facilities and consistent with American Society of Reproductive Medicine guidelines. The bill also excludes experimental fertility procedures and nonmedical costs associated with donor gametes, donor embryos, or surrogacy. The act would take effect October 1, 2025, and apply to insurance contracts issued, renewed, or amended on or after that date.
Impact
H635 would amend Chapter 58 of the North Carolina General Statutes by adding a new insurance coverage mandate for fertility-related services in the large group market. Its main legal effect is to expand required benefits in employer-sponsored large group health plans, while expressly exempting self-insured plans and religious employers. The bill would affect insurers, large group policyholders, and insured individuals seeking fertility evaluation, IVF, and fertility preservation, and it would likely increase covered benefits and potentially insurance costs for affected plans.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the overall sentiment appears supportive and policy-driven, with the bill framed as an access-expansion measure. The sponsorship and title suggest an intent to improve fertility care availability rather than restrict it. No recorded opposition, amendments, or divided votes are included in the provided context, so there is no documented controversy in the available record.
Contention
The main points of contention likely center on the scope and cost of the coverage mandate. Potential concerns include the requirement to cover at least three IVF cycles, the impact on premiums for large group plans, and whether fertility preservation should be mandated as a covered benefit. Exemptions for self-insured plans and religious institutions may also be debated, as they limit the reach of the mandate and could be viewed either as necessary carveouts or as gaps in access. The exclusions for experimental procedures and nonmedical surrogacy-related costs further define the bill’s boundaries and may be relevant to stakeholders in reproductive medicine and insurance.